MGC Pharmaceuticals Limited PDMR Notification (3972G)
July 18 2023 - 6:41AM
UK Regulatory
TIDMMXC
RNS Number : 3972G
MGC Pharmaceuticals Limited
18 July 2023
MGC Pharmaceuticals Ltd.
PDMR Notification
18 July 2023
ASX, LSE: MXC
MGC Pharmaceuticals Ltd ('MGC Pharma' or 'the Company')
announces, further to the Company's "GBP0.7 million Fundraising"
announcement on 14 July 2023, details of the participation of
Persons Discharging Managerial Responsibilities ("PDMRs") in the
Subscription in accordance with the UK Market Abuse
regulations.
Full details of the shares subscribed by the PDMRs in the
Subscription are contained in the disclosure tables below.
Capitalised terms not otherwise defined in this announcement
shall have the same meaning ascribed to them in the Company's
announcement made on 14 July 2023.
1 Details of the person discharging managerial responsibilities/person
closely associated
(a) Name Amir Polak
-------------------------------------- ------------------------------------------
2 Reason for the notification
----------------------------------------------------------------------------------
(a) Position Chief Pharmaceutical Development
Officer
-------------------------------------- ------------------------------------------
(b) Initial notification/amendment Initial
-------------------------------------- ------------------------------------------
(c) If amendment: reason n/a
-------------------------------------- ------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
----------------------------------------------------------------------------------
Full name of entity MGC Pharmaceuticals Limited
-------------------------------------- ------------------------------------------
Legal Entity Identifier 213800HRE3FQJ6RK4H10
Code
-------------------------------------- ------------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; (iv) each place where transactions
have been conducted
----------------------------------------------------------------------------------
(a) Description of the financial Fully Paid Ordinary Shares
instrument, type of
instrument
-------------------------------------- ------------------------------------------
(b) Identification Code AU000000MXC6
(ISIN)
-------------------------------------- ------------------------------------------
(c) Nature of transaction Shares issued following participation
in fundraise
-------------------------------------- ------------------------------------------
(d) Currency Price Volume Total
----------------- --------------------- --------------- -----------------------
GBP GBP0.0012 4,416,667 GBP5,300
----------------- --------------------- --------------- -----------------------
Aggregated information
----------------------------------------------------------------------------------
GBP GBP0.0012 4,416,667 GBP5,300
----------------- --------------------- --------------- -----------------------
(e) Date of transaction 14 July 2023
-------------------------------------- ------------------------------------------
(f) Place of transaction Outside a trading venue
-------------------------------------- ------------------------------------------
1 Details of the person discharging managerial responsibilities/person
closely associated
(a) Name Itay Nissim
-------------------------------------- ------------------------------------------
2 Reason for the notification
----------------------------------------------------------------------------------
(a) Position Chief Manufacturing and Supply
Chain Officer
-------------------------------------- ------------------------------------------
(b) Initial notification/amendment Initial
-------------------------------------- ------------------------------------------
(c) If amendment: reason n/a
-------------------------------------- ------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
----------------------------------------------------------------------------------
Full name of entity MGC Pharmaceuticals Limited
-------------------------------------- ------------------------------------------
Legal Entity Identifier 213800HRE3FQJ6RK4H10
Code
-------------------------------------- ------------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; (iv) each place where transactions
have been conducted
----------------------------------------------------------------------------------
(a) Description of the financial Fully Paid Ordinary Shares
instrument, type of
instrument
-------------------------------------- ------------------------------------------
(b) Identification Code AU000000MXC6
(ISIN)
-------------------------------------- ------------------------------------------
(c) Nature of transaction Shares issued following participation
in fundraise
-------------------------------------- ------------------------------------------
(d) Currency Price Volume Total
----------------- --------------------- --------------- -----------------------
GBP GBP0.0012 3,833,333 GBP4,600
----------------- --------------------- --------------- -----------------------
Aggregated information
----------------------------------------------------------------------------------
GBP GBP0.0012 3,833,333 GBP4,600
----------------- --------------------- --------------- -----------------------
(e) Date of transaction 14 July 2023
-------------------------------------- ------------------------------------------
(f) Place of transaction Outside a trading venue
-------------------------------------- ------------------------------------------
1 Details of the person discharging managerial responsibilities/person
closely associated
(a) Name Yair Tal
-------------------------------------- ------------------------------------------
2 Reason for the notification
----------------------------------------------------------------------------------
(a) Position Chief Information Security Officer
-------------------------------------- ------------------------------------------
(b) Initial notification/amendment Initial
-------------------------------------- ------------------------------------------
(c) If amendment: reason n/a
-------------------------------------- ------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
----------------------------------------------------------------------------------
Full name of entity MGC Pharmaceuticals Limited
-------------------------------------- ------------------------------------------
Legal Entity Identifier 213800HRE3FQJ6RK4H10
Code
-------------------------------------- ------------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; (iv) each place where transactions
have been conducted
----------------------------------------------------------------------------------
(a) Description of the financial Fully Paid Ordinary Shares
instrument, type of
instrument
-------------------------------------- ------------------------------------------
(b) Identification Code AU000000MXC6
(ISIN)
-------------------------------------- ------------------------------------------
(c) Nature of transaction Shares issued following participation
in fundraise
-------------------------------------- ------------------------------------------
(d) Currency Price Volume Total
----------------- --------------------- --------------- -----------------------
GBP GBP0.0012 2,166,667 GBP2,600
----------------- --------------------- --------------- -----------------------
Aggregated information
----------------------------------------------------------------------------------
GBP GBP0.0012 2,166,667 GBP2,600
----------------- --------------------- --------------- -----------------------
(e) Date of transaction 14 July 2023
-------------------------------------- ------------------------------------------
(f) Place of transaction Outside a trading venue
-------------------------------------- ------------------------------------------
1 Details of the person discharging managerial responsibilities/person
closely associated
(a) Name Yifat Steuer
-------------------------------------- ------------------------------------------
2 Reason for the notification
----------------------------------------------------------------------------------
(a) Position Chief Operating Officer and Deputy
CEO
-------------------------------------- ------------------------------------------
(b) Initial notification/amendment Initial
-------------------------------------- ------------------------------------------
(c) If amendment: reason n/a
-------------------------------------- ------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
----------------------------------------------------------------------------------
Full name of entity MGC Pharmaceuticals Limited
-------------------------------------- ------------------------------------------
Legal Entity Identifier 213800HRE3FQJ6RK4H10
Code
-------------------------------------- ------------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; (iv) each place where transactions
have been conducted
----------------------------------------------------------------------------------
(a) Description of the financial Fully Paid Ordinary Shares
instrument, type of
instrument
-------------------------------------- ------------------------------------------
(b) Identification Code AU000000MXC6
(ISIN)
-------------------------------------- ------------------------------------------
(c) Nature of transaction Shares issued following participation
in fundraise
-------------------------------------- ------------------------------------------
(d) Currency Price Volume Total
----------------- --------------------- --------------- -----------------------
GBP GBP0.0012 5,833,333 GBP7,000
----------------- --------------------- --------------- -----------------------
Aggregated information
----------------------------------------------------------------------------------
GBP GBP0.0012 5,833,333 GBP7,000
----------------- --------------------- --------------- -----------------------
(e) Date of transaction 14 July 2023
-------------------------------------- ------------------------------------------
(f) Place of transaction Outside a trading venue
-------------------------------------- ------------------------------------------
--Ends--
Authorised for release by the Managing Director, for further
information please contact:
MGC Pharmaceuticals Ltd MGC Pharmaceuticals Ltd
Roby Zomer Arron Canicais / Rowan Harland
CEO & Managing Director Joint Company Secretaries
+61 8 6382 3390 +61 8 6382 3390
info@mgcpharma.co.uk info@mgcpharma.co.uk
UK Brokers UK Brokers
Peterhouse Capital Oberon Capital
Charles Goodfellow / Lucy Williams Adam Pollock / Aimee McCusker
/ Duncan Vasey +44 203 179 5300
+44 207 469 0930 adampollock@oberoninvestments.com
mgcpharma@tavistock.co.uk aimeemccusker@oberoninvestments.com
UK IR/PR Advisers
IDC Advisory
Graham Herring / Tim Metcalfe /
Zach Cohen
mgcpharma@investor-focus.co.uk
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHEAEXPFDPDEFA
(END) Dow Jones Newswires
July 18, 2023 06:41 ET (10:41 GMT)
Mgc Pharmaceuticals (LSE:MXC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Mgc Pharmaceuticals (LSE:MXC)
Historical Stock Chart
From Jul 2023 to Jul 2024
